Kbc Group Nv Amphastar Pharmaceuticals, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,509 shares of AMPH stock, worth $67,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,509

Previous 1,509 -0.0%

Holding current value

$67,225

Previous $60,000 21.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$38.65 - $43.48 $20,793 - $23,392	538 Added 55.41%	1,509 $60,000
Q4 2023 Feb 13, 2024	SELL	$44.49 - $62.93 $80,037 - $113,211	-1,799 Reduced 64.95%	971 $60,000
Q3 2023 Feb 15, 2024	SELL	$45.51 - $65.0 $75,910 - $108,420	-1,668 Reduced 60.22%	1,102 $51,000
Q2 2023 Feb 15, 2024	SELL	$35.77 - $58.38 $14,594 - $23,819	-408 Reduced 12.84%	2,770 $159,000
Q2 2023 Jul 28, 2023	SELL	$35.77 - $58.38 $14,594 - $23,819	-408 Reduced 12.84%	2,770 $159,000
Q3 2022 Feb 15, 2024	BUY	$27.56 - $37.75 $60,824 - $83,314	2,207 Added 227.29%	3,178 $89,000
Q2 2022 Feb 14, 2024	BUY	$29.79 - $42.29 $65,746 - $93,334	2,207 Added 227.29%	3,178 $111,000
Q2 2022 Jul 26, 2022	BUY	$29.79 - $42.29 $94,672 - $134,397	3,178 New	3,178 $111,000
Q1 2020 May 04, 2020	SELL	$12.66 - $20.08 $531,960 - $843,741	-42,019 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$18.92 - $22.96 $257,084 - $311,980	-13,588 Reduced 24.44%	42,019 $0
Q4 2018 Jan 31, 2019	SELL	$17.72 - $22.51 $284,335 - $361,195	-16,046 Reduced 22.39%	55,607 $1.11 Million
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $119,764 - $150,815	7,782 Added 12.18%	71,653 $0
Q2 2018 Aug 03, 2018	BUY	$14.63 - $19.6 $38,476 - $51,548	2,630 Added 4.29%	63,871 $0
Q1 2018 May 09, 2018	BUY	$17.23 - $20.35 $262,326 - $309,828	15,225 Added 33.09%	61,241 $0
Q3 2017 Nov 13, 2017	BUY	$14.73 - $17.99 $677,815 - $827,827	46,016	46,016 $0

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.18B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account